References
1. Messé, S. R. et al. Practice advisory update summary: Patent
foramen ovale and secondary stroke prevention. Neurology (2020)
doi:10.1212/wnl.0000000000009443.
2. Pristipino, C. et al. European position paper on the
management of patients with patent foramen ovale. General approach and
left circulation thromboembolism. Eur. Heart J. (2019)
doi:10.1093/eurheartj/ehy649.
3. Silvestry, F. E. et al. Guidelines for the Echocardiographic
Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the
American Society of Echocardiography and Society for Cardiac Angiography
and Interventions. J. Am. Soc. Echocardiogr. (2015)
doi:10.1016/j.echo.2015.05.015.
4. Mancini, M. E., Muratori, M., Agostoni, P. & Trabattoni, D. When a
patent foramen ovale device is no more in place: silent patent foramen
ovale occluder device migration to the aortic arch. Eur. Hear. J.
- Case Reports 3 , (2019).
5. Goel, S. S., Aksoy, O., Tuzcu, E. M., Krasuski, R. A. & Kapadia, S.
R. Embolization of patent foramen ovale closure devices: Incidence, role
of imaging in identification, potential causes, and management.Texas Hear. Inst. J. (2013).
6. Vitarelli, A. et al. Echocardiographic findings in simple and
complex patent foramen ovale before and after transcatheter closure.Eur. Heart J. Cardiovasc. Imaging (2014)
doi:10.1093/ehjci/jeu143.
7. Bartel, T., Bonatti, J. O. & Müller, S. Device Dislocation, Probably
Due to Paroxysmal Coughing Early After Percutaneous Closure of Secundum
Type Atrial Septal Defect. Am. J. Cardiol. (2008)
doi:10.1016/j.amjcard.2007.08.059.
8. Schoof, S., Norozi, K., Breymann, T., Wessel, A. & Bertram, H. Cough
a potentially life-threatening condition after interventional closure of
atrial septal defect. Circ. Cardiovasc. Imaging (2009)
doi:10.1161/CIRCIMAGING.108.808873.
9. Devendra, G. P., Rane, A. A. & Krasuski, R. A. Provoked exercise
desaturation in patent foramen ovale and impact of percutaneous closure.JACC Cardiovasc. Interv. (2012) doi:10.1016/j.jcin.2012.01.011.